Detailed information for compound 1144288

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 251.247 | Formula: C12H9N7
  • H donors: 2 H acceptors: 4 LogP: 1.02 Rotable bonds: 2
    Rule of 5 violations (Lipinski): 1
  • SMILES: c1[nH]nc(c1)c1cnc2n1cc(cn2)c1c[nH]nc1
  • InChi: 1S/C12H9N7/c1-2-15-18-10(1)11-6-14-12-13-3-9(7-19(11)12)8-4-16-17-5-8/h1-7H,(H,15,18)(H,16,17)
  • InChiKey: MQGHHLZJAHJXPY-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens checkpoint kinase 2 Starlite/ChEMBL References
Homo sapiens checkpoint kinase 1 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Brugia malayi Protein kinase domain containing protein Get druggable targets OG5_130454 All targets in OG5_130454
Echinococcus multilocularis calcium:calmodulin dependent protein kinase I Get druggable targets OG5_128695 All targets in OG5_128695
Candida albicans protein kinase Get druggable targets OG5_128695 All targets in OG5_128695
Echinococcus multilocularis serine:threonine protein kinase Chk2 Get druggable targets OG5_128695 All targets in OG5_128695
Schistosoma mansoni serine/threonine protein kinase Get druggable targets OG5_130454 All targets in OG5_130454
Schistosoma japonicum ko:K06641 serine/threonine-protein kinase Chk2, putative Get druggable targets OG5_128695 All targets in OG5_128695
Schistosoma mansoni serine/threonine protein kinase Get druggable targets OG5_128695 All targets in OG5_128695
Schistosoma japonicum Serine/threonine-protein kinase Chk1, putative Get druggable targets OG5_130454 All targets in OG5_130454
Candida albicans kinase involved in DNA repair Get druggable targets OG5_128695 All targets in OG5_128695
Entamoeba histolytica protein kinase, putative Get druggable targets OG5_128695 All targets in OG5_128695
Echinococcus granulosus serine:threonine protein kinase Chk2 Get druggable targets OG5_128695 All targets in OG5_128695
Candida albicans kinase involved in DNA repair Get druggable targets OG5_128695 All targets in OG5_128695
Candida albicans protein kinase Get druggable targets OG5_128695 All targets in OG5_128695
Loa Loa (eye worm) CAMK/CAMKL/CHK1 protein kinase Get druggable targets OG5_130454 All targets in OG5_130454
Echinococcus granulosus calcium:calmodulin dependent protein kinase I Get druggable targets OG5_128695 All targets in OG5_128695
Entamoeba histolytica protein kinase, putative Get druggable targets OG5_128695 All targets in OG5_128695

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trypanosoma cruzi PAB1-binding protein , putative 0.0027 0.0527 1
Schistosoma mansoni serine/threonine protein kinase 0.0202 1 1
Brugia malayi ImpB/MucB/SamB family protein 0.0021 0.0179 0.0179
Schistosoma mansoni tar DNA-binding protein 0.0069 0.2777 0.2646
Leishmania major hypothetical protein, conserved 0.0027 0.0527 1
Echinococcus multilocularis geminin 0.0185 0.9037 1
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0099 0.4376 0.4274
Brugia malayi hypothetical protein 0.0027 0.0527 0.0527
Giardia lamblia DINP protein human, muc B family 0.0021 0.0179 0.5
Brugia malayi RNA binding protein 0.0069 0.2777 0.2777
Loa Loa (eye worm) hypothetical protein 0.0027 0.0527 0.0355
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0099 0.4376 0.4739
Schistosoma mansoni tar DNA-binding protein 0.0069 0.2777 0.2646
Echinococcus multilocularis calcium:calmodulin dependent protein kinase I 0.0046 0.1552 0.1551
Mycobacterium ulcerans DNA polymerase IV 0.0021 0.0179 0.5
Entamoeba histolytica protein kinase, putative 0.0046 0.1553 1
Brugia malayi ImpB/MucB/SamB family protein 0.0021 0.0179 0.0179
Schistosoma mansoni hypothetical protein 0.0185 0.9037 0.902
Schistosoma mansoni tar DNA-binding protein 0.0069 0.2777 0.2646
Trypanosoma brucei PAB1-binding protein , putative 0.0027 0.0527 1
Plasmodium falciparum ataxin-2 like protein, putative 0.0027 0.0527 0.5
Echinococcus granulosus serine:threonine protein kinase Chk2 0.0046 0.1553 0.1552
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0099 0.4376 0.4739
Echinococcus multilocularis serine:threonine protein kinase Chk2 0.0046 0.1553 0.1552
Trypanosoma cruzi PAB1-binding protein , putative 0.0027 0.0527 1
Loa Loa (eye worm) TAR-binding protein 0.0069 0.2777 0.2646
Loa Loa (eye worm) RNA binding protein 0.0069 0.2777 0.2646
Schistosoma mansoni tar DNA-binding protein 0.0069 0.2777 0.2646
Schistosoma mansoni tar DNA-binding protein 0.0069 0.2777 0.2646
Echinococcus granulosus calcium:calmodulin dependent protein kinase I 0.0046 0.1552 0.1551
Mycobacterium tuberculosis Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) 0.0021 0.0179 0.5
Brugia malayi GTP-binding regulatory protein Gs alpha-S chain, putative 0.0099 0.4376 0.4376
Entamoeba histolytica protein kinase, putative 0.0046 0.1553 1
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0099 0.4376 0.4739
Trichomonas vaginalis DNA polymerase eta, putative 0.0021 0.0179 0.5
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0099 0.4376 0.4739
Loa Loa (eye worm) CAMK/CAMKL/CHK1 protein kinase 0.0202 1 1
Trichomonas vaginalis DNA polymerase IV / kappa, putative 0.0021 0.0179 0.5
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0099 0.4376 0.4274
Echinococcus granulosus geminin 0.0185 0.9037 1
Schistosoma mansoni hypothetical protein 0.0185 0.9037 0.902
Plasmodium falciparum ataxin-2 like protein, putative 0.0027 0.0527 0.5
Mycobacterium ulcerans DNA polymerase IV 0.0021 0.0179 0.5
Schistosoma mansoni serine/threonine protein kinase 0.0046 0.1553 0.14
Mycobacterium tuberculosis Conserved hypothetical protein 0.0021 0.0179 0.5
Brugia malayi RNA recognition motif domain containing protein 0.0069 0.2777 0.2777
Plasmodium vivax ataxin-2 like protein, putative 0.0027 0.0527 0.5
Loa Loa (eye worm) RNA recognition domain-containing protein domain-containing protein 0.0069 0.2777 0.2646
Echinococcus multilocularis tar DNA binding protein 0.0069 0.2777 0.2934
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0099 0.4376 0.4274
Echinococcus granulosus tar DNA binding protein 0.0069 0.2777 0.2934
Toxoplasma gondii LsmAD domain-containing protein 0.0027 0.0527 0.5
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain 0.0099 0.4376 0.4274
Brugia malayi TAR-binding protein 0.0069 0.2777 0.2777

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 0.48 uM Inhibition of CHK2 by DELFIA assay ChEMBL. 20561787
IC50 (binding) = 1.5 uM Inhibition of CHK1 by DELFIA ChEMBL. 20561787
Inhibition (binding) = -6 % Inhibition of AKT1 at 10 uM by mobility shift assay ChEMBL. 20561787
Inhibition (binding) = -6 % Inhibition of ERk2 at 10 uM by mobility shift assay ChEMBL. 20561787
Inhibition (binding) = -3 % Inhibition of p38alpha at 10 uM by mobility shift assay ChEMBL. 20561787
Inhibition (binding) = -2 % Inhibition of AKT2 at 10 uM by mobility shift assay ChEMBL. 20561787
Inhibition (binding) = 7 % Inhibition of PRAK1 at 10 uM by mobility shift assay ChEMBL. 20561787
Inhibition (binding) = 10 % Inhibition of ERk1 at 10 uM by mobility shift assay ChEMBL. 20561787
Inhibition (binding) = 11 % Inhibition of MSK1 at 10 uM by mobility shift assay ChEMBL. 20561787
Inhibition (binding) = 13 % Inhibition of MAPKAP2 at 10 uM by mobility shift assay ChEMBL. 20561787
Inhibition (binding) = 13 % Inhibition of MET at 10 uM by mobility shift assay ChEMBL. 20561787
Inhibition (binding) = 13 % Inhibition of INSR at 10 uM by mobility shift assay ChEMBL. 20561787
Inhibition (binding) = 23 % Inhibition of PKCz at 10 uM by mobility shift assay ChEMBL. 20561787
Inhibition (binding) = 26 % Inhibition of PKD2 at 10 uM by mobility shift assay ChEMBL. 20561787
Inhibition (binding) = 58 % Inhibition of GSK3-beta at 10 uM by mobility shift assay ChEMBL. 20561787
Inhibition (binding) = 63 % Inhibition of ABL1 at 10 uM by mobility shift assay ChEMBL. 20561787
Inhibition (binding) = 72 % Inhibition of RSK1 at 10 uM by mobility shift assay ChEMBL. 20561787
Inhibition (binding) = 74 % Inhibition of LYN at 10 uM by mobility shift assay ChEMBL. 20561787
Inhibition (binding) = 75 % Inhibition of CK1d at 10 uM by mobility shift assay ChEMBL. 20561787
Inhibition (binding) = 75 % Inhibition of CHK1 at 10 uM by mobility shift assay ChEMBL. 20561787
Inhibition (binding) = 85 % Inhibition of SRC at 10 uM by mobility shift assay ChEMBL. 20561787
Inhibition (binding) = 86 % Inhibition of LCK at 10 uM by mobility shift assay ChEMBL. 20561787
Inhibition (binding) = 88 % Inhibition of FYN at 10 uM by mobility shift assay ChEMBL. 20561787
Inhibition (binding) = 95 % Inhibition of Aur A at 10 uM by mobility shift assay ChEMBL. 20561787
Inhibition (binding) = 95 % Inhibition of CHK2 at 10 uM by DELFIA assay ChEMBL. 20561787

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.